Skip to content

4Accepted Oct 15, 4:33 PM ET

TRex Bio: 10% owner Alexandria Venture Investments bought 1,346,501 shares

TRXBTRex Bio, Inc.

Accepted (ET)

4:33 PM

Oct 15, 2026

Filed

Oct 15, 2026

Documents

1

Size

10.6 KB

Summary

TRex Bio: 10% owner Alexandria Venture Investments bought 1,346,501 shares

Updated

What happened

  • Alexandria Venture Investments, LLC, a 10% owner, reported conversions of derivative securities into common stock and an open market or private purchase.
  • The filing shows acquisitions of 1,167,930 shares via conversion and 178,571 shares purchased at $14.00 for $2,499,994, and dispositions of 1,033,541 shares and 3,480,387 shares via conversion (priced at $0.00).

Key details

  • Transaction date: Oct 13, 2026. Filing date: Oct 15, 2026.
  • Purchases: 178,571 shares at $14.00 per share for $2,499,994 (transaction code P).
  • Conversions (transaction code C): acquired 1,167,930 shares; disposed 1,033,541 shares and 3,480,387 shares (each conversion shown at $0.00).
  • Shares owned after the transactions: not specified in the filing.
  • Footnote: each share of preferred stock automatically converted into the issuer's common stock at a ratio of 3.8649 preferred shares to 1 common share upon closing of the issuer's initial public offering on Oct 13, 2026, for no additional consideration; the shares had no expiration date.
  • Transaction codes per the filing: C = conversion of derivative security, P = open market or private purchase.

Why it may matter

  • Conversion: the filing records conversion of derivative securities (preferred stock) into common stock under the stated 3.8649-to-1 ratio upon the issuer's IPO.
  • Purchase: the filing shows a market/private purchase of 178,571 shares at $14.00 for $2,499,994.
  • 10% owner: Alexandria Venture Investments is a large holder (10% owner), not an executive.
  • The filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing